NeribiOm is seeking to discover bioengineered probiotic bacteria strains (Live Biotherapeutics Products, LBP) their
secretomes and prebiotics to propose highly innovative therapeutics based on control of microbiota-gut-brain axis dysfunctions (dysbiosis)